Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir and Nitazoxanide in Early COVID-19
NCT04918927Phase 2Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Oct 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in coronavirus disease 2019 (COVID-19), sponsored by Coordinación de Investigación en Salud. Started Oct 2021; status: completed.
02
Drugs
nitazoxanide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04918927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918927.